anemia: develop in patients

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents sickle cell anemia
Weight: 0.80
, symptom
Weight: 0.65
, complication
Weight: 0.65
, abnormality
Weight: 0.64
, condition
Weight: 0.60
Siblings hemolytic anemia
Weight: 0.83
, thalassemia
Weight: 0.50
, liver cancer
Weight: 0.36
, pulmonary edema
Weight: 0.36
, hypertension
Weight: 0.35

Related properties

Property Similarity
develop in patients 1.00
be common in patients 0.90
be common in patients with scd 0.89
develop in patients with leukemia 0.88
be common in patients receiving 0.84
develop in polycystic kidney disease 0.80
develop in kidney disease 0.79
develop with maintenance dialysis 0.78
nurse diagnosis 0.76
be from stress different hypertension caused renal disease 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.08
Rule weight: 0.13
Evidence weight: 0.78
Similarity weight: 0.76
Evidence: 0.56
¬ Remarkable(anemia, develop in patients)
Evidence: 0.39
¬ Remarkable(pulmonary edema, nurse diagnosis)
0.07
Rule weight: 0.13
Evidence weight: 0.64
Similarity weight: 0.80
Evidence: 0.56
¬ Remarkable(anemia, develop in patients)
Evidence: 0.65
¬ Remarkable(hypertension, develop in polycystic kidney disease)
0.07
Rule weight: 0.13
Evidence weight: 0.66
Similarity weight: 0.76
Evidence: 0.56
¬ Remarkable(anemia, develop in patients)
Evidence: 0.61
¬ Remarkable(hypertension, be from stress different hypertension caused renal disease)

Remarkability from sibling implausibility

0.42
Rule weight: 0.60
Evidence weight: 0.87
Similarity weight: 0.80
Evidence: 0.60
Plausible(anemia, develop in patients)
Evidence: 0.65
Remarkable(hypertension, develop in polycystic kidney disease)
Evidence: 0.95
¬ Plausible(hypertension, develop in polycystic kidney disease)
0.39
Rule weight: 0.60
Evidence weight: 0.85
Similarity weight: 0.76
Evidence: 0.60
Plausible(anemia, develop in patients)
Evidence: 0.61
Remarkable(hypertension, be from stress different hypertension caused renal disease)
Evidence: 0.97
¬ Plausible(hypertension, be from stress different hypertension caused renal disease)
0.38
Rule weight: 0.60
Evidence weight: 0.83
Similarity weight: 0.76
Evidence: 0.60
Plausible(anemia, develop in patients)
Evidence: 0.39
Remarkable(pulmonary edema, nurse diagnosis)
Evidence: 0.68
¬ Plausible(pulmonary edema, nurse diagnosis)

Salient implies Plausible

0.21
Rule weight: 0.28
Evidence weight: 0.74
Similarity weight: 1.00
Evidence: 0.60
Plausible(anemia, develop in patients)
Evidence: 0.65
¬ Salient(anemia, develop in patients)

Similarity expansion

0.58
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.90
Evidence: 0.66
Typical(anemia, develop in patients)
Evidence: 0.71
¬ Typical(anemia, be common in patients)
0.57
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.89
Evidence: 0.56
Remarkable(anemia, develop in patients)
Evidence: 0.56
¬ Remarkable(anemia, be common in patients with scd)
0.57
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.90
Evidence: 0.65
Salient(anemia, develop in patients)
Evidence: 0.72
¬ Salient(anemia, be common in patients)
0.57
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.90
Evidence: 0.56
Remarkable(anemia, develop in patients)
Evidence: 0.57
¬ Remarkable(anemia, be common in patients)
0.57
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.84
Evidence: 0.56
Remarkable(anemia, develop in patients)
Evidence: 0.45
¬ Remarkable(anemia, be common in patients receiving)
0.56
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.90
Evidence: 0.60
Plausible(anemia, develop in patients)
Evidence: 0.65
¬ Plausible(anemia, be common in patients)
0.54
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.89
Evidence: 0.65
Salient(anemia, develop in patients)
Evidence: 0.82
¬ Salient(anemia, be common in patients with scd)
0.54
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.89
Evidence: 0.66
Typical(anemia, develop in patients)
Evidence: 0.84
¬ Typical(anemia, be common in patients with scd)
0.53
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.84
Evidence: 0.65
Salient(anemia, develop in patients)
Evidence: 0.72
¬ Salient(anemia, be common in patients receiving)
0.53
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.89
Evidence: 0.60
Plausible(anemia, develop in patients)
Evidence: 0.77
¬ Plausible(anemia, be common in patients with scd)
0.52
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.88
Evidence: 0.66
Typical(anemia, develop in patients)
Evidence: 0.91
¬ Typical(anemia, develop in patients with leukemia)
0.52
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.88
Evidence: 0.56
Remarkable(anemia, develop in patients)
Evidence: 0.71
¬ Remarkable(anemia, develop in patients with leukemia)
0.51
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.84
Evidence: 0.66
Typical(anemia, develop in patients)
Evidence: 0.81
¬ Typical(anemia, be common in patients receiving)
0.51
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.84
Evidence: 0.60
Plausible(anemia, develop in patients)
Evidence: 0.71
¬ Plausible(anemia, be common in patients receiving)
0.50
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.78
Evidence: 0.66
Typical(anemia, develop in patients)
Evidence: 0.73
¬ Typical(anemia, develop with maintenance dialysis)
0.50
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.88
Evidence: 0.65
Salient(anemia, develop in patients)
Evidence: 0.97
¬ Salient(anemia, develop in patients with leukemia)
0.48
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.78
Evidence: 0.65
Salient(anemia, develop in patients)
Evidence: 0.79
¬ Salient(anemia, develop with maintenance dialysis)
0.48
Rule weight: 0.85
Evidence weight: 0.64
Similarity weight: 0.88
Evidence: 0.60
Plausible(anemia, develop in patients)
Evidence: 0.89
¬ Plausible(anemia, develop in patients with leukemia)
0.48
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.78
Evidence: 0.56
Remarkable(anemia, develop in patients)
Evidence: 0.65
¬ Remarkable(anemia, develop with maintenance dialysis)
0.48
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.78
Evidence: 0.60
Plausible(anemia, develop in patients)
Evidence: 0.72
¬ Plausible(anemia, develop with maintenance dialysis)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.87
Similarity weight: 1.00
Evidence: 0.65
Salient(anemia, develop in patients)
Evidence: 0.66
¬ Typical(anemia, develop in patients)
Evidence: 0.56
¬ Remarkable(anemia, develop in patients)

Typical implies Plausible

0.35
Rule weight: 0.48
Evidence weight: 0.74
Similarity weight: 1.00
Evidence: 0.60
Plausible(anemia, develop in patients)
Evidence: 0.66
¬ Typical(anemia, develop in patients)

Typicality and Rermarkability incompatibility between siblings

0.06
Rule weight: 0.14
Evidence weight: 0.55
Similarity weight: 0.76
Evidence: 0.56
¬ Remarkable(anemia, develop in patients)
Evidence: 0.81
¬ Typical(pulmonary edema, nurse diagnosis)
0.05
Rule weight: 0.14
Evidence weight: 0.45
Similarity weight: 0.80
Evidence: 0.56
¬ Remarkable(anemia, develop in patients)
Evidence: 0.98
¬ Typical(hypertension, develop in polycystic kidney disease)
0.05
Rule weight: 0.14
Evidence weight: 0.45
Similarity weight: 0.76
Evidence: 0.56
¬ Remarkable(anemia, develop in patients)
Evidence: 1.00
¬ Typical(hypertension, be from stress different hypertension caused renal disease)